AstraZeneca acquires EsoBiotec for $1billion in a bid to push its cell therapy agenda
HQ Team March 17, 2025: AstraZeneca has announced plans to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies, for up to.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team March 17, 2025: AstraZeneca has announced plans to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies, for up to.
Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.
HQ Team July 18, 2024: In a reversal strategy in the war against cancer, researchers are now aiming to genetically cloak healthy cells.
HQ team November 3, 2023: Researchers at Michigan Medicine, University of Michigan, have discovered a key metabolite’s role in regulating DNA repair processes,.
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency.
Alembic Pharmaceuticals got the USFDA note for a generic cancer treatment drug